Cohen P - Search Results

1

Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.

Lee WT, Tamai H, Cohen P, Teker AM, Shu S. Lee WT, et al. Among authors: cohen p. Arch Otolaryngol Head Neck Surg. 2008 Jun;134(6):608-13. doi: 10.1001/archotol.134.6.608. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18559727

2

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.

Kuriyama H, Watanabe S, Kjaergaard J, Tamai H, Zheng R, Weinberg AD, Hu HM, Cohen PA, Plautz GE, Shu S. Kuriyama H, et al. Cell Immunol. 2006 Sep;243(1):30-40. doi: 10.1016/j.cellimm.2006.11.002. Epub 2007 Jan 17. Cell Immunol. 2006. PMID: 17207783

3

Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy.

Shu S, Zheng R, Lee WT, Cohen PA. Shu S, et al. Crit Rev Immunol. 2007;27(5):463-83. doi: 10.1615/critrevimmunol.v27.i5.50. Crit Rev Immunol. 2007. PMID: 18197808 Review.

4

Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.

Tamai H, Watanabe S, Zheng R, Deguchi K, Cohen PA, Koski GK, Shu S. Tamai H, et al. Clin Immunol. 2008 Apr;127(1):66-77. doi: 10.1016/j.clim.2007.12.001. Epub 2008 Feb 11. Clin Immunol. 2008. PMID: 18262845

5

Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines.

Cho EI, Tan C, Koski GK, Cohen PA, Shu S, Lee WT. Cho EI, et al. Head Neck. 2010 Jun;32(6):700-7. doi: 10.1002/hed.21241. Head Neck. 2010. PMID: 19908319

6

Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids.

Lee WT, Tan C, Koski G, Shu S, Cohen P. Lee WT, et al. Among authors: cohen p. Head Neck. 2010 Sep;32(9):1209-16. doi: 10.1002/hed.21323. Head Neck. 2010. PMID: 20054852

7

Tumor-dendritic cell fusion technology and immunotherapy strategies.

Shu S, Cohen P. Shu S, et al. Among authors: cohen p. J Immunother. 2001 Mar-Apr;24(2):99-100. J Immunother. 2001. PMID: 11265778 No abstract available.

8

Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy.

Wang LX, Kjaergaard J, Cohen PA, Shu S, Plautz GE. Wang LX, et al. J Immunol. 2004 Mar 15;172(6):3462-8. doi: 10.4049/jimmunol.172.6.3462. J Immunol. 2004. PMID: 15004146

9

Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.

Zheng R, Kjaergaard J, Lee WT, Cohen PA, Shu S. Zheng R, et al. Cancer Treat Res. 2007;135:223-37. doi: 10.1007/978-0-387-69219-7_17. Cancer Treat Res. 2007. PMID: 17953420 Review. No abstract available.

10

Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12.

Zheng R, Cohen PA, Paustian CA, Johnson TD, Lee WT, Shu S, Koski GK. Zheng R, et al. Cancer Res. 2008 Jun 1;68(11):4045-9. doi: 10.1158/0008-5472.CAN-07-6669. Cancer Res. 2008. PMID: 18519662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,345 results

Search Page

Filters